FLGT Fulgent Genetics Inc

Fulgent Genetics Inc is a technology company offering genetic testing to provide physicians with clinically actionable diagnostic information used to improve the overall quality of patient care.

$38.98  +1.20 (3.18%)
As of 10/04/2022 12:18:07 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  09/29/2016
Outstanding shares:  30,327,203
Average volume:  304,596
Market cap:   $1,156,072,978
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYQBFQ5
Valuation   (See tab for details)
PE ratio:   2.49
PB ratio:   0.88
PS ratio:   1.21
Return on equity:   35.27%
Net income %:   48.32%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy